MemAntine.com
Title
memantine.com - Innovation for Alzheimer Patients
Description
Excerpted from the website description:
- Memantine is the first and only representative of a new class of Alzheimer drugs - a moderate affinity NMDA-receptor antagonist. Memantine has been developed by Merz Pharmaceuticals and was recently approved in Europe and the USA for the treatment of moderate to severe Alzheimer's disease. In addition memantine is available in Mexico and in several South American countries.
Languages
English
Address
- Eckenheimer Landstrasse 100-104
- Frankfurt/Main D-60318 GERMANY
Contact
- Merz und Co. GmbH
-
- +49 691503285, Fax: +49 691503402
